Pharming Group N.V. (PHAR) Operating income 2019–2025
Pharming Group N.V. (PHAR) annual operating income history from SEC filings — each fiscal year as reported.
$25.8MFY2025 · since FY2019: $68.2M → $25.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $25.8M | +399.8% |
| FY2024 | -$8.6M | -60.0% |
| FY2023 | -$5.4M | -129.5% |
| FY2022 | $18.2M | +34.5% |
| FY2021 | $13.6M | -82.2% |
| FY2020 | $76.3M | +11.7% |
| FY2019 | $68.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PHAR financial trends
PHAR RevenuePHAR Net incomePHAR Net marginPHAR Gross profitPHAR Gross marginPHAR Operating marginPHAR Operating cash flowPHAR Free cash flowPHAR Capital expendituresPHAR Return on equityPHAR Stock buybacksPHAR Dividends paidPHAR Total assetsPHAR Total liabilitiesPHAR Shareholders’ equityPHAR overview →